Return to Statistics Toolbox

Pathway mapping for Study ST003435

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:NA | Sample Type:Blank | Drug Treatment:NA (3)
Sample source:NA | Sample Type:QC | Drug Treatment:NA (2)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:1 nM rotenone (3)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:20 uM Fasnall (3)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:40 uM Fasnall (3)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:40 uM GSK2194069 (3)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:40 uM TVB-2640 (3)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:5 nM rotenone (3)
Sample source:Zebrafish medium | Sample Type:Zebrafish medium | Drug Treatment:Vehicle (3)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:1 nM rotenone (3)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:20 uM Fasnall (3)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:40 uM Fasnall (3)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:40 uM GSK2194069 (4)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:40 uM TVB-2640 (3)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:5 nM rotenone (4)
Sample source:Zebrafish | Sample Type:Zebrafish embryo metabolite extract | Drug Treatment:Vehicle (3)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo